High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study - Quiz - MDSpire

High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study

  • By

  • Cainan Yu

  • Minghua Zhang

  • Jie Hui

  • Mengqing Zhu

  • Zengtian Sun

  • Yueyue Sun

  • Qian Sun

  • Zhiling Yan

  • Feng Zhu

  • Mingshan Niu

  • Depeng Li

  • Kunming Qi

  • June 29, 2026

  • 0 min

Share

Original Source(s)

High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study

  • by Cainan Yu, Minghua Zhang, Jie Hui, Mengqing Zhu, Zengtian Sun, Yueyue Sun, Qian Sun, Zhiling Yan, Feng Zhu, Mingshan Niu, Depeng Li, Kunming Qi

  • June 29, 2026

Related Content

Network analysis of distress, symptom burden, social support, and digital health literacy in older postoperative patients with gastric cancer

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

Prehabilitation in cancer care: an evolving field